A 60-year-old with AF and eGFR 30 on apixaban develops UGIB. After endoscopic hemostasis and stabilization, when should anticoagulation generally be r...

Question

A 60-year-old with AF and eGFR 30 on apixaban develops UGIB. After endoscopic hemostasis and stabilization, when should anticoagulation generally be resumed to balance thromboembolism and bleeding?

Accepted Answer

Within 7-14 days depending on risk

Answer

Never resume

Answer

Wait 3 months

Answer

Resume within 24 hours in all

Answer

Switch to aspirin only

us-abim MCQ (SBA): Resuming OAC After GI Bleed

A 60-year-old with AF and eGFR 30 on apixaban develops UGIB. After endoscopic hemostasis and stabilization, when should anticoagulation generally be resumed to balance thromboembolism and bleeding?